(Nasdaq: BDSX), a leading diagnostics solutions company, announced the publication of the largest lung nodule biomarker clinical validation study ever conducted. This milestone strengthens the ...
Diagnostic tunnel vision by 2 pulmonologists led to a $2 million malpractice settlement after the patient died of esophageal cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results